FindTrial
Sign In

Efficacy of two Therapeutic Techniques for the Treatment of Greater Tuberosity Fractures

Efficacy of two Therapeutic Techniques for the Treatment of Greater Tuberosity Fractures

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1900025567
Enrollment
Unknown
Registered
2019-09-01
Start date
2019-10-01
Completion date
Unknown
Last updated
2019-09-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Greater Tuberosity Fractures

Interventions

ORIF group:Open Reduction Internal Fixation (ORIF)
arthroscope group:arthroscope

Sponsors

Ruijin Hospital Shanghai JiaoTong University School of Medcine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. understand and have signed the informed consent; 2. participant age older than 18 years old; 3. diagnosis of Greater Tuberosity Fractures by X-ray or Scanner, Neer type II or AO class 11-A1-2/3; 4. fractures within 2 weeks.

Exclusion criteria

Exclusion criteria: 1. unable to understand doctors' advice; 2. other fractures ipsilateral; 3. histroy of open fracture, pathological fracture, rheumarthritis; 4. Associated vascular or nerve injuries; 5. have participated other clinical trials 4 weeks before our study; 6. patients with ipsilateral previous proximal humeral fractures.

Design outcomes

Primary

MeasureTime frame
Constant-Murley score;—

Secondary

MeasureTime frame
ASES score;VAS score;post operation complication;—

Contacts

Public ContactLei Wang

Ruijin Hospital Shanghai JiaoTong University School of Medicine

ray_wangs66@163.com+86 13636624388

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026